Literature DB >> 19003085

The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein.

Trish Benton1, Tim Chen, Michele McEntee, Brian Fox, David King, Robert Crombie, Thomas C Thomas, Christopher Bebbington.   

Abstract

UCOE vectors contain non-tissue specific chromatin-opening-elements that permit rapid expression of a protein in anintegration independent manner. Efficient expression can bederived from a single copy of an integrated gene site resulting ina higher percentage of cells expressing the marker gene in theselected pool in comparison to standard non-UCOE containingvectors. This, in combination with the utilization of a serum-free, suspension adapted parent cell line allows for rapidproduction of large quantities of protein in a short period oftime. Utilizing this system more than 300 mg of a recombinantantibody has been produced in less than 1 month from transfectionpools in shake flask. Selected subclones have been scaled intosmall bioreactors in less than 2 months, producing significantquantities of monoclonal antibody using a protocol generic for theparent cell line. The increased efficiency obtained with the UCOEvector reduces the number of transfectants which need to bescreened in order to obtain high productivity subclones.Transfection of a standard host cell line, preadapted to grow in alarge-scale setting, allows for rapid cell line developmentdecreasing the transition time from research into development andmanufacturing. Alternatively, the traditional approach of using aparent cell line which requires serum-free and suspensionadaptation after transfection further increases the need forscreening a large number of subclones, because many of thesubclones will not be able to grow under conditions that allowlarge-scale protein production. The use of a preadapted cell linecan reduce the time required to develop a cell line from months toweeks.

Year:  2002        PMID: 19003085      PMCID: PMC3449923          DOI: 10.1023/A:1021141712344

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  7 in total

1.  A soluble form of alpha1,3-galactosyltransferase functions within cells to galactosylate glycoproteins.

Authors:  S K Cho; R D Cummings
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

2.  Association of G1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells.

Authors:  J A D'Anna; J G Valdez; R C Habbersett; H A Crissman
Journal:  Radiat Res       Date:  1997-09       Impact factor: 2.841

3.  The chromosomes of CHO, an aneuploid Chinese hamster cell line: G-band, C-band, and autoradiographic analyses.

Authors:  L L Deaven; D F Petersen
Journal:  Chromosoma       Date:  1973       Impact factor: 4.316

4.  Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?

Authors:  C K Borrebaeck; A C Malmborg; M Ohlin
Journal:  Immunol Today       Date:  1993-10

5.  Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection.

Authors:  E Gorelik; L Duty; F Anaraki; U Galili
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

6.  Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells.

Authors:  Y Kagawa; S Takasaki; J Utsumi; K Hosoi; H Shimizu; N Kochibe; A Kobata
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

7.  Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects.

Authors:  T T PUCK; S J CIECIURA; A ROBINSON
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

  7 in total
  21 in total

1.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

2.  Toward more efficient protein expression: keep the message simple.

Authors:  Stephan Kalwy; James Rance; Robert Young
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

3.  Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction.

Authors:  Fabien Palazzoli; Solenne Bire; Yves Bigot; Florence Bonnin-Rouleux
Journal:  Nat Biotechnol       Date:  2011-07-11       Impact factor: 54.908

4.  Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells.

Authors:  Zeynep Betts; Alan J Dickson
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

5.  Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.

Authors:  Yasuto Yamaguchi; Xiao-Yan Du; Lei Zhao; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

6.  Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.

Authors:  Botond Z Igyártó; Krystal Haley; Daniela Ortner; Aleh Bobr; Maryam Gerami-Nejad; Brian T Edelson; Sandra M Zurawski; Bernard Malissen; Gerard Zurawski; Judith Berman; Daniel H Kaplan
Journal:  Immunity       Date:  2011-07-21       Impact factor: 31.745

7.  Effects of ubiquitous chromatin opening element (UCOE) on recombinant anti-TNFα antibody production and expression stability in CHO-DG44 cells.

Authors:  Chinh Chung Doan; Thanh Long Le; Nguyen Quynh Chi Ho; Nghia Son Hoang
Journal:  Cytotechnology       Date:  2021-10-23       Impact factor: 2.058

Review 8.  Molecular-genetic imaging of cancer.

Authors:  Il Minn; Mitchell E Menezes; Siddik Sarkar; Keerthi Yarlagadda; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher; Martin G Pomper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Heterologous protein production using euchromatin-containing expression vectors in mammalian cells.

Authors:  Katalin Zboray; Wolfgang Sommeregger; Edith Bogner; Andreas Gili; Thomas Sterovsky; Katharina Fauland; Beatrice Grabner; Patricia Stiedl; Herwig P Moll; Anton Bauer; Renate Kunert; Emilio Casanova
Journal:  Nucleic Acids Res       Date:  2015-05-14       Impact factor: 16.971

10.  Use of transgenic animals in biotechnology: prospects and problems.

Authors:  O G Maksimenko; A V Deykin; Yu M Khodarovich; P G Georgiev
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.